Christopher J. Nardo - 02 Jan 2026 Form 4 Insider Report for Dermata Therapeutics, Inc. (DRMA)

Role: Senior VP, CDO
Signature: /s/ Gerald T. Proehl, Attorney-in-Fact
Issuer symbol: DRMA
Transactions as of: 02 Jan 2026
Net transactions value: $0
Form type: 4
Filing time: 06 Jan 2026, 20:00:08 UTC
Previous filing: 14 Jan 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Nardo Christopher J.	Senior VP, CDO	3525 DEL MAR HEIGHTS RD., #322, SAN DIEGO	/s/ Gerald T. Proehl, Attorney-in-Fact	06 Jan 2026	0001870247

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	DRMA	Stock Option (right to buy)	Award	$0	+18,000		$0.000000	18,000	02 Jan 2026	Common Stock	18,000	$2.18	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares underlying the option will vest as to 25% upon the 12 month anniversary of the grant date, and will vest as to 75% in 36 equal monthly installments commencing on the 12 month anniversary of the grant date.